Opentrons' subsidiary Neochromosome and Mekonos announce new partnership to advance cell engineering for personalized medicine
/PRNewswire/ -- Mekonos, Inc., a biotech platform company building the future of cell therapies on a chip, has announced a new partnership with Neochromosome,...
Source: prnewswire.com